ConductScience.org, home

Paper27367478

'Acute myeloid leukemia: a comprehensive review and 2016 update'.

De Kouchkovsky I and 1 other. Blood Cancer J, 2016. Cited by 999 papers, by iCite.

Cite this record

ConductScience Library. 'Acute myeloid leukemia: a comprehensive review and 2016 update'. Papers, record 27367478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27367478

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
'Acute myeloid leukemia: a comprehensive review and 2016 update'.
PubMed
Journal
Blood Cancer J
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
999
iCite
Relative citation ratio, by iCite
34.1
iCite
Revised in PubMed
2022-03-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Kouchkovsky II
2Abdul-Hay MM

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
Humans
Immunotherapy
Molecular Targeted Therapy
Prognosis

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04392310Outcomes of Acute Myeloid Leukemia PatientsBackgroundClinicalTrials.gov
NCT04708444Prognostic Value of CD318 in AML at Assiut University Hospital.BackgroundClinicalTrials.gov
NCT06483906Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.BackgroundClinicalTrials.gov

Download CSV of trials

References114

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125993000High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials.PLoS One2015https://conductscience.org/library/papers/25993000PubMed
216921041Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.J Clin Oncol2006https://conductscience.org/library/papers/16921041PubMed
320952518Phase I study of sorafenib in patients with refractory or relapsed acute leukemias.Haematologica2011https://conductscience.org/library/papers/20952518PubMed
422039260Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.Blood2012https://conductscience.org/library/papers/22039260PubMed
525887778Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.Blood2015https://conductscience.org/library/papers/25887778PubMed
68874180A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.Blood1996https://conductscience.org/library/papers/8874180PubMed
724726781Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.Leuk Res2014https://conductscience.org/library/papers/24726781PubMed
810023702Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.Cancer1999https://conductscience.org/library/papers/10023702PubMed
918064533Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002.Cancer Causes Control2008https://conductscience.org/library/papers/18064533PubMed
1017213292
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Blood2007https://conductscience.org/library/papers/17213292PubMed
112045861Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.J Clin Oncol1991https://conductscience.org/library/papers/2045861PubMed
1224623852Crenolanib is a selective type I pan-FLT3 inhibitor.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24623852PubMed
1325449688Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.Leuk Res2014https://conductscience.org/library/papers/25449688PubMed
1425721896CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.Leukemia2015https://conductscience.org/library/papers/25721896PubMed
1520212254Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.J Clin Oncol2010https://conductscience.org/library/papers/20212254PubMed
1616051734Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.Blood2005https://conductscience.org/library/papers/16051734PubMed
1723558173Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.Science2013https://conductscience.org/library/papers/23558173PubMed
1826811524
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.
J Clin Oncol2016https://conductscience.org/library/papers/26811524PubMed
192475589
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.
J Clin Oncol1989https://conductscience.org/library/papers/2475589PubMed
2023786647Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study.Br J Haematol2013https://conductscience.org/library/papers/23786647PubMed

See all 114 referencesDownload CSV of references

Cited by718

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 999 citations.

PMIDTitleJournalYearIn PapersSource
42977970FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications.Biomark Res2026https://conductscience.org/library/papers/42977970PubMed
42919186Effects of azacitidine combined with venetoclax on inflammatory markers and overall response rate in elderly patients with newly diagnosed acute myeloid leukemia.BMC Geriatr2026https://conductscience.org/library/papers/42919186PubMed
42881859Combining the Telomerase Inhibitor Imetelstat with the BCL-2 Inhibitor Venetoclax Enhances Apoptosis and Improves Survival in Acute Myeloid Leukemia Cellular and Animal Models.J Clin Med2026https://conductscience.org/library/papers/42881859PubMed
42814135Very Long Chain Fatty Acid Synthesis is a Targetable Dependency in RAS Pathway Mutant Leukemia.Blood Cancer Discov2026https://conductscience.org/library/papers/42814135PubMed
42807630Hereditary Predisposition to Acute Myeloid Leukemia: A Novel Germline CEBPA Mutation in a Multigenerational Family.Case Rep Hematol2026https://conductscience.org/library/papers/42807630PubMed
42688360More precise risk stratification for de novo acute myeloid leukemia with double-mutation CEBPA.Ther Adv Hematol2026https://conductscience.org/library/papers/42688360PubMed
42589161Molecular Docking and Simulation-Based Exploration of Niclosamide as a Potential Inhibitor of the p62 ZZ Domain.Biology (Basel)2026https://conductscience.org/library/papers/42589161PubMed
42541488Sodium Overload-Related Molecular Subtypes and a Four-Gene Prognostic Signature Predict Survival, Immune Landscape, and Therapeutic Response in Acute Myeloid Leukemia.Mol Carcinog2026https://conductscience.org/library/papers/42541488PubMed
42507679A systems biology approach to find representative genes in Acute Myeloid Leukemia.PLoS One2026https://conductscience.org/library/papers/42507679PubMed
42499707RSK signaling in myeloid malignancies: biology, disease dependency, and therapeutic targeting.Front Cell Dev Biol2026https://conductscience.org/library/papers/42499707PubMed
42438298DHX15 affects AML1-ETO9a splicing together with HNRNPL, RBM33 in AML1-ETO-positive acute myeloid leukaemia.Br J Haematol2026https://conductscience.org/library/papers/42438298PubMed
42434847QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemia.Future Oncol2026https://conductscience.org/library/papers/42434847PubMed
42412348Incidence, etiology, and predictors of early mortality after induction chemotherapy for aml in a middle-income country.Int J Hematol2026https://conductscience.org/library/papers/42412348PubMed
42388349Identification of long non-coding RNAs involved in leukemogenesis and venetoclax response in acute myeloid leukemia through functional CRISPR-dCas9 interference screens.Noncoding RNA Res2026https://conductscience.org/library/papers/42388349PubMed
42350371Mitochondrial integrated stress response activation creates a therapeutic vulnerability to MCL-1 inhibition in acute myeloid leukemia.Cell Death Dis2026https://conductscience.org/library/papers/42350371PubMed
42279389Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies.Cancers (Basel)2026https://conductscience.org/library/papers/42279389PubMed
42265630Upregulation of NFS1 and downregulation of GSDMD as prognostic biomarkers in acute myeloid leukemia: implications for diagnosis and therapeutic strategies.BMC Cancer2026https://conductscience.org/library/papers/42265630PubMed
42243832Exploring CAR cell therapies beyond CAR-T for myeloid malignancies.J Biomed Sci2026https://conductscience.org/library/papers/42243832PubMed
42095623Arginine deprivation induces prolonged autophagy activation and ROS-dependent cell death in glioblastoma multiforme.CNS Oncol2026https://conductscience.org/library/papers/42095623PubMed
42087483Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 Mutations.Cancer Med2026https://conductscience.org/library/papers/42087483PubMed

See all 718 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CBFB865PubTator's text mininghttps://conductscience.org/library/genes/865NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD33945PubTator's text mininghttps://conductscience.org/library/genes/945NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD37951PubTator's text mininghttps://conductscience.org/library/genes/951NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CEBPA1050PubTator's text mininghttps://conductscience.org/library/genes/1050NCBI Gene
CXADRP1653108PubTator's text mininghttps://conductscience.org/library/genes/653108NCBI Gene
DEK7913PubTator's text mininghttps://conductscience.org/library/genes/7913NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
FOLR22350PubTator's text mininghttps://conductscience.org/library/genes/2350NCBI Gene
GATA22624PubTator's text mininghttps://conductscience.org/library/genes/2624NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IDH23418PubTator's text mininghttps://conductscience.org/library/genes/3418NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
KMT2A4297PubTator's text mininghttps://conductscience.org/library/genes/4297NCBI Gene
MLLT34300PubTator's text mininghttps://conductscience.org/library/genes/4300NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27367478

GET https://conductscience.org/api/papers/v1/27367478/references?page=2